ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Five Group Chairs Discuss Mergers In A Q&A

March 11, 2011

NCI Budget Chief John Hartinger Retires.

August 4, 2006

Edwards’ NIH Pep Talk Sounded Like An Attack On The Cancer Program, But He Says It Wasn’t

March 8, 1974

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

IOM Report Urges Providers To Address Psychological Needs Of Cancer Patients.

November 23, 2007